Mette Husbyn joined Vaccibody in October 2017. She holds a PhD in peptide chemistry from University of Oslo, 2003.
Mette has since 1990 worked in CMC drug development throughout all clinical stages from early research to NDA/MAA filings. Mette started her pharmaceutical career in Nycomed Pharma, Oslo as a scientist, followed by assignments within diagnostic imaging in Amersham Health and GE Healthcare, Oslo in various roles (lead scientist, project manager, department manager) over a period of 10 years. Most recently she held the CMC Manager position in Lytix Biopharma, Oslo for over five years, where she was responsible for all CMC related issues, including regulatory within both the antimicrobial and immune oncology programmes.